Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BiltRx vs Teleios Health

BiltRx
Graded #60

Higher grade

vs+14.799999999999997
Teleios Health
Graded #328

Lower grade

The verdict

BiltRx takes it — 75/100 to 60.2/100.

BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBiltRx +6
90
84
Dose & formulationBiltRx +21
85
64
Clinical oversightBiltRx +25
74
49
Labs & monitoringBiltRx +4
52
48
FulfillmentBiltRx +29
71
42
Contract termsEven
55
55
BiltRx · left barTeleios Health · right bar

The numbers

MetricBiltRxTeleios Health
WeighScore75/10060.2/100
GradeCC
Scorecard rank#60#328
Semaglutide$125/mo (all doses, compounded)$99/mo (starting dose, compounded)
Tirzepatide$129/mo (all doses, compounded)$139/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
BiltRx

Graded #60 · C

Strengths

  • Very low starting prices (semaglutide from 125 dollars, tirzepatide from 129 dollars)
  • LegitScript verified and HIPAA compliant
  • Names its 503A compounding pharmacies (Boothwyn and Southend)
  • Offers both compounded and brand-name GLP-1 options

Where it loses points

  • Covered states are behind a check-availability gate, not listed
  • Starting prices may rise depending on plan and dose
Teleios Health

Graded #328 · C

Strengths

  • Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
  • Compounded tirzepatide from a competitive $139/mo floor
  • Markets physician (MD/DO) prescribing rather than an NP-only model
  • Clean meta-tag and SEO implementation

Where it loses points

  • Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
  • No named medical director, physician, or corporate entity disclosed
  • Year founded unknown — a newer floor-price entrant warranting extra scrutiny
  • No LegitScript, NABP, or SOC 2 trust signal found
  • Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard